Clinical trial Recruiting at 2 sites Observational Ages 55 to 75

Testing early signs of dementia in patients with smell disorders

Official title: Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With idiOpathic anosMiA

Run by Danish Dementia Research Centre · NCT05740683 · Data updated 2026-11-12

This study is trying to see if people with smell problems show early signs of dementia with Lewy bodies, using a new test to help catch it sooner.

More Olfactory Dysfunction trials

Quick facts

Study typeObservational
Ages55 Years to 75 Years
SexAll
Enrollment100 (estimated)
SponsorDanish Dementia Research Centre
Research network
Locations2 sites (Copenhagen and 1 other locations)
StatusRecruiting
StartedFebruary 1, 2023
Main results expectedDecember 2032
Study endsDecember 2032
Registry record updatedOctober 2, 2024
Trial IDNCT05740683 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 55-75 with slowly progressing idiopathic olfactory dysfunction.

Probably not a fit

Patients with diagnosed neurodegenerative diseases or those whose olfactory dysfunction is due to other medical conditions will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the relationship between idiopathic olfactory dysfunction and early warning signs of dementia with Lewy bodies (DLB). It utilizes a novel technique called Real-Time Quaking-Induced Conversion (RT-QuIC) to measure misfolded alpha-synuclein in patients with olfactory dysfunction compared to healthy controls. The study seeks to identify biomarkers and prodromal symptoms that could facilitate earlier diagnosis and intervention for DLB. By understanding these early signs, the research hopes to improve patient care and support the development of disease-modifying therapies.

Why it matters

Potential benefit: If successful, this study could lead to earlier diagnosis and treatment options for patients at risk of developing dementia.

How similar studies have gone: While the approach of using RT-QuIC is novel, similar studies have shown promise in identifying early biomarkers for neurodegenerative diseases.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria with patients iOD:

* Age 55 -75 years of age
* Slowly progressing and non-fluctuating iOD
* Able to give informed consent and to cooperate as evaluated by the PI

Exclusion criteria with patients iOD:

* Diagnosed with a neurodegenerative disease or major neurological/psychiatric condition.
* Anosmia/hyposmia caused by sino-nasal disease (including chronic rhinitis and allergy), after trauma, infection, congenial, olfactory dysfunction due to surgery, or toxins/drugs affecting the olfactory function.
* Olfactory dysfunction with response to systemic or local corticosteroids if tried
* Severe nasal cavity abnormalities or infections.
* Overt signs of dementia or PD
* Current alcohol or drug abuse
* Terminal illness
* Diagnosed with neurodegenerative disease or major neurological/psychiatric condition.

Inclusion criteria controls:

* Age 55 -75 years of age
* Able to give informed consent
* Able to cooperate as evaluated by the PI

Exclusion criteria controls:

* Olfactory dysfunction on clinical test
* Overt signs of dementia or PD
* Severe nasal cavity abnormalities or infections.
* Current alcohol or drug abuse
* Diagnosed with neurodegenerative disease or major neurological/psychiatric condition.

Where it's running

  • Danish Dementia Research Centre
    Copenhagen, Denmark
    Recruiting
  • Oskar McWilliam
    Copenhagen, Denmark
    Recruiting

Study contacts

  • Principal investigator: Kristian S Frederiksen — Danish Dementia Research Centre, Rigshospitalet, Capital Region
  • Study coordinator: Oskar McWilliam
  • Email: oskar.mcwilliam@regionh.dk
  • Phone: +4535458759

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.